Wells Fargo & Company »

Silence Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Silence Therapeutics (SLN) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Silence Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silence Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silence Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-09-30 $345 19 18.16

More positions owned by Wells Fargo & Company

Microsoft Corporation (MSFT)
Apple Put Option (AAPL)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p Ttl Stk (ITOT)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon (AMZN)
JPMorgan Chase & Co. Put Option (JPM)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core Msci Eafe (IEFA)
UnitedHealth (UNH)
Broadcom (AVGO)

View all positions for Wells Fargo & Company

Top funds holding Silence Therapeutics

TCG Crossover Management
Siren
Redmile Group
Logos Global Management
Deep Track Capital
Frazier Life Sciences Management
Nextech Invest
Henderson Group
Eventide Asset Management
Cormorant Asset Management
Ikarian Capital
5AM Venture Management
Point72 Asset Management
Citadel Advisors
Woodline Partners

View all funds holding Silence Therapeutics